• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟苯达唑在不同类型癌症中发挥重要的抗肿瘤作用。

Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers.

作者信息

Chen Chaoran, Ding Yueming, Liu Huiyang, Sun Mengyao, Wang Honggang, Wu Dongdong

机构信息

Institute of Nursing and Health, School of Nursing and Health, Henan University, Jinming Avenue, Kaifeng 475004, China.

Henan International Joint Laboratory of Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.

出版信息

Int J Mol Sci. 2022 Jan 4;23(1):519. doi: 10.3390/ijms23010519.

DOI:10.3390/ijms23010519
PMID:35008943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8745596/
Abstract

Flubendazole, belonging to benzimidazole, is a broad-spectrum insect repellent and has been repurposed as a promising anticancer drug. In recent years, many studies have shown that flubendazole plays an anti-tumor role in different types of cancers, including breast cancer, melanoma, prostate cancer, colorectal cancer, and lung cancer. Although the anti-tumor mechanism of flubendazole has been studied, it has not been fully understood. In this review, we summarized the recent studies regarding the anti-tumor effects of flubendazole in different types of cancers and analyzed the related mechanisms, in order to provide the theoretical reference for further studies in the future.

摘要

氟苯达唑属于苯并咪唑类,是一种广谱驱虫剂,已被重新用作一种有前景的抗癌药物。近年来,许多研究表明氟苯达唑在不同类型的癌症中发挥抗肿瘤作用,包括乳腺癌、黑色素瘤、前列腺癌、结直肠癌和肺癌。尽管已经对氟苯达唑的抗肿瘤机制进行了研究,但尚未完全了解。在本综述中,我们总结了关于氟苯达唑在不同类型癌症中的抗肿瘤作用的最新研究,并分析了相关机制,以便为未来的进一步研究提供理论参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5183/8745596/f9adfa26fba3/ijms-23-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5183/8745596/f9adfa26fba3/ijms-23-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5183/8745596/f9adfa26fba3/ijms-23-00519-g001.jpg

相似文献

1
Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers.氟苯达唑在不同类型癌症中发挥重要的抗肿瘤作用。
Int J Mol Sci. 2022 Jan 4;23(1):519. doi: 10.3390/ijms23010519.
2
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.氟苯达唑,一种经美国食品药品监督管理局批准的驱虫药,通过靶向 P53 并促进去势抵抗性前列腺癌中的铁死亡,发挥有效的抗肿瘤作用。
Pharmacol Res. 2021 Feb;164:105305. doi: 10.1016/j.phrs.2020.105305. Epub 2020 Nov 14.
3
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.氟苯达唑通过靶向 EVA1A 调节的自噬和凋亡在三阴性乳腺癌中发挥抗癌作用。
Theranostics. 2020 Jul 2;10(18):8080-8097. doi: 10.7150/thno.43473. eCollection 2020.
4
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.驱虫药氟苯达唑可抑制人黑色素瘤的生长和转移,并抑制程序性细胞死亡蛋白-1 和髓源抑制细胞的积累。
Cancer Lett. 2019 Sep 10;459:268-276. doi: 10.1016/j.canlet.2019.05.026. Epub 2019 May 23.
5
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.氟苯达唑是一种经美国食品药品监督管理局批准的驱虫药,可靶向乳腺癌干细胞样细胞。
Oncotarget. 2015 Mar 20;6(8):6326-40. doi: 10.18632/oncotarget.3436.
6
[Flubendazole Inhibits the Proliferation of A549 and H460 Cells and Promotes Autophagy].[氟苯达唑抑制A549和H460细胞增殖并促进自噬]
Zhongguo Fei Ai Za Zhi. 2020 May 20;23(5):306-313. doi: 10.3779/j.issn.1009-3419.2020.104.17.
7
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.驱虫药氟苯达唑通过一种不同于长春花生物碱的机制抑制微管功能,并在白血病和骨髓瘤中显示出临床前活性。
Blood. 2010 Jun 10;115(23):4824-33. doi: 10.1182/blood-2009-09-243055. Epub 2010 Mar 26.
8
Emerging insights on functions of the anthelmintic flubendazole as a repurposed anticancer agent.驱虫药氟苯达唑作为一种重新定位的抗癌药物的功能的新见解。
Cancer Lett. 2021 Dec 1;522:57-62. doi: 10.1016/j.canlet.2021.09.013. Epub 2021 Sep 11.
9
Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy.抗蠕虫药氟苯达唑及其在抗癌治疗中的潜在用途。
Acta Medica (Hradec Kralove). 2017;60(1):5-11. doi: 10.14712/18059694.2017.44. Epub 2017 Apr 11.
10
The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells.氟苯达唑对SW480和SW620结肠癌细胞黏附和迁移的影响。
Anticancer Agents Med Chem. 2018;18(6):837-846. doi: 10.2174/1871520618666171213141911.

引用本文的文献

1
Anticancer role of flubendazole: Effects and molecular mechanisms (Review).氟苯达唑的抗癌作用:效应与分子机制(综述)
Oncol Lett. 2024 Sep 20;28(6):558. doi: 10.3892/ol.2024.14691. eCollection 2024 Dec.
2
Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.解锁前列腺癌中的铁死亡——通向新型治疗方法和成像标志物的道路。
Nat Rev Urol. 2024 Oct;21(10):615-637. doi: 10.1038/s41585-024-00869-9. Epub 2024 Apr 16.
3
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer.

本文引用的文献

1
Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway.他莫昔芬通过靶向细胞浆雌激素受体α与 EGFR/HER2 信号通路的串扰克服 SK-BR-3 肿瘤球对曲妥珠单抗的耐药性。
Biochem Pharmacol. 2021 Aug;190:114635. doi: 10.1016/j.bcp.2021.114635. Epub 2021 May 28.
2
A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells.一种克服癌症干细胞样细胞化疗耐药性的纳米治疗策略。
Nat Nanotechnol. 2021 Jan;16(1):104-113. doi: 10.1038/s41565-020-00793-0. Epub 2021 Jan 12.
3
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
氟苯达唑通过 HIF1α/PI3K/AKT 信号通路增强紫杉醇对乳腺癌的抑制作用。
Int J Mol Sci. 2023 Oct 12;24(20):15121. doi: 10.3390/ijms242015121.
4
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.通过计算驱动的药物再利用鉴定治疗前列腺癌的有前途的候选药物。
Int J Mol Sci. 2023 Feb 5;24(4):3135. doi: 10.3390/ijms24043135.
5
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors.药物重新利用以增强对PD-1/PD-L1免疫检查点抑制剂的抗肿瘤反应。
Cancers (Basel). 2022 Jul 11;14(14):3368. doi: 10.3390/cancers14143368.
氟苯达唑,一种经美国食品药品监督管理局批准的驱虫药,通过靶向 P53 并促进去势抵抗性前列腺癌中的铁死亡,发挥有效的抗肿瘤作用。
Pharmacol Res. 2021 Feb;164:105305. doi: 10.1016/j.phrs.2020.105305. Epub 2020 Nov 14.
4
The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs.苯并咪唑驱虫药作为重新利用药物的抗肿瘤潜力
Immune Netw. 2020 Aug 4;20(4):e29. doi: 10.4110/in.2020.20.e29. eCollection 2020 Aug.
5
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.氟苯达唑通过靶向 EVA1A 调节的自噬和凋亡在三阴性乳腺癌中发挥抗癌作用。
Theranostics. 2020 Jul 2;10(18):8080-8097. doi: 10.7150/thno.43473. eCollection 2020.
6
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers.MALAT1的表达促进HER2过表达乳腺癌中的曲妥珠单抗耐药。
Cancers (Basel). 2020 Jul 16;12(7):1918. doi: 10.3390/cancers12071918.
7
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.靶向肿瘤相关巨噬细胞和粒细胞性髓系来源的抑制细胞增强胆管癌的 PD-1 阻断。
J Clin Invest. 2020 Oct 1;130(10):5380-5396. doi: 10.1172/JCI137110.
8
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole.分析氟苯达唑处理的黑色素瘤细胞中诱导有丝分裂灾难的细胞反应。
Toxicol In Vitro. 2020 Oct;68:104930. doi: 10.1016/j.tiv.2020.104930. Epub 2020 Jul 8.
9
Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study.口腔病变进展为口腔鳞状细胞癌中 PD-1 和 PD-L1 的表达增加:一项初步研究。
Sci Rep. 2020 Jun 16;10(1):9705. doi: 10.1038/s41598-020-66257-6.
10
Whipworm and roundworm infections.鞭虫和蛔虫感染。
Nat Rev Dis Primers. 2020 May 28;6(1):44. doi: 10.1038/s41572-020-0171-3.